Shanxi Qianyecao Biotech QYC
Ordered peptides from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it.
Test my supplyAcross a broad, recent lab record, Shanxi Qianyecao Biotech QYC shows its strongest purity-focus evidence in GHK-Cu and Tirzepatide, with passing identity, high purity, and acceptable fill. The catalog is uneven: Retatrutide is volatile, while BPC-157 and Cagrilintide carry repeated purity, identity, or fill misses, and missing batch IDs add uncertainty.
Registry records put QYC’s named PRC entity in cancelled status while the sales identity kept posting in 2026. The report traces dead channels, Batch Unknown COAs, a downstream reseller trail and payment rails that leave the current operator unresolved.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Shanxi Qianyecao Biotech QYC rows.
Cancel anytime
Ordered peptides from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
14 Oct 2026 | Pass | Retatrutide Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
5 Sep 2026 | Pass | PT-141 Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
4 Sep 2026 | Fail | Sermorelin Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
9 Aug 2026 | Pass | GHK-Cu Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
5 Aug 2026 | Fail | Retatrutide Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
5 Aug 2026 | Fail | Ipamorelin Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
4 Aug 2026 | Fail | Retatrutide Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
4 Aug 2026 | Fail | NAD+ Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
23 Jul 2026 | Pass | BPC-157 Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
21 Jul 2026 | Pass | Tesamorelin Shanxi Qianyecao Biotech QYC | lab name | View COA | |||
About Shanxi Qianyecao Biotech QYC test results from Finnrick
Shanxi Qianyecao Biotech QYC is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 132 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Shanxi Qianyecao Biotech QYC peptides in this dataset are BPC-157 (8 tests), Cagrilintide (5 tests) and GHK-Cu (13 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 132 recent tests. It also includes 1 correction related to this vendor.
Ordered peptides from Shanxi Qianyecao Biotech QYC? Mail in a sample (US only) and let us test it.
Test my supply